SARS‐CoV‐2 Omicron variant: Characteristics and prevention
Top Cited Papers
Open Access
- 13 December 2021
- Vol. 2 (4), 838-845
- https://doi.org/10.1002/mco2.110
Abstract
Coronavirus disease 2019 (COVID-19) has brought about a great threat to global public health. Recently, a new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant B.1.1.529 has been reported in South Africa and induced a rapid increase in COVID-19 cases. On November 24, 2021, B.1.1.529 named Omicron was designated as a variant under monitoring (VUM) by World Health Organization (WHO). Two days later, the Omicron variant was classified as a variant of concern (VOC). This variant harbors a high number of mutations, including 15 mutations in the receptor-binding domain (RBD) of spike. The Omicron variant also shares several mutations with the previous VOC Alpha, Beta, and Gamma variants, which immediately raised global concerns about viral transmissibility, pathogenicity, and immune evasion. Here we described the discovery and characteristics of the Omicron variant, compared the mutations of the spike in the five VOCs, and further raised possible strategies to prevent and overcome the prevalence of the Omicron variant.Keywords
Funding Information
- National Natural Science Foundation of China (81800421)
This publication has 26 references indexed in Scilit:
- A bivalent recombinant vaccine targeting the S1 protein induces neutralizing antibodies against both SARS‐CoV‐2 variants and wild‐type of the virusMedcomm, 2021
- Complete map of SARS-CoV-2 RBD mutations that escape the monoclonal antibody LY-CoV555 and its cocktail with LY-CoV016Cell Reports Medicine, 2021
- Complete map of SARS-CoV-2 RBD mutations that escape the monoclonal antibody LY-CoV555 and its cocktail with LY-CoV016Published by Cold Spring Harbor Laboratory ,2021
- Early transmissibility assessment of the N501Y mutant strains of SARS-CoV-2 in the United Kingdom, October to November 2020Eurosurveillance, 2021
- Evaluating the Effects of SARS-CoV-2 Spike Mutation D614G on Transmissibility and PathogenicityCell, 2021
- Spike mutation D614G alters SARS-CoV-2 fitnessNature, 2020
- Recognition of the SARS-CoV-2 receptor binding domain by neutralizing antibodiesBiochemical and Biophysical Research Communications, 2020
- Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 VirusCell, 2020
- Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptorNature, 2020
- Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2Science, 2020